Maravai LifeSciences Holdings, Inc. Share Price
Stocks
MRVI
US56600D1072
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 7.810 USD | -7.68% |
|
+10.47% | +140.31% |
| 10-05 | TD Cowen Initiates Maravai Lifesciences at Buy With $9 Price Target | MT |
| 09-29 | Maravai's TriLink Gets New China Patent for CleanCap Technology | MT |
| Market Cap | 1.26B 1.13B 1.04B 941M 1.76B 120B 1.79B 12.38B 4.97B 62.96B 4.73B 4.63B 199B | P/E 2026 * |
-26.4x | P/E 2027 * | -32.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.35B 1.21B 1.12B 1.01B 1.89B 129B 1.92B 13.3B 5.34B 67.62B 5.08B 4.97B 213B | EV / Sales 2026 * |
6.39x | EV / Sales 2027 * | 5.87x |
| Free-Float |
45.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MRVI | Delayed | |
CBOE
| MRVI | Real-time | |
|
Tradegate
| MAR | Real-time | |
|
Börse Stuttgart
| MAR | Delayed | |
|
Deutsche Boerse AG
| MAR | Delayed |
Last Transcript: Maravai LifeSciences Holdings, Inc.
| 1 day | -7.68% | ||
| 1 week | +10.47% | ||
| Current month | +1.96% | ||
| 1 month | +2.09% | ||
| 3 months | +18.51% | ||
| 6 months | +124.43% | ||
| Current year | +140.31% |
| 1 week | 7.32 |  | 8.62 |
| 1 month | 6.33 | | 8.74 |
| Current year | 2.8 | | 9.42 |
| 1 year | 2.54 | | 9.42 |
| 3 years | 1.66 | | 11.56 |
| 5 years | 1.66 | | 46.43 |
| 10 years | 1.66 | | 63.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bernd Brust
CEO | Chief Executive Officer | 59 | 07/06/2025 |
| Director of Finance/CFO | 59 | 29/06/2025 | |
Elie Chaaya
COO | Chief Operating Officer | - | 31/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Cunningham
BRD | Director/Board Member | 50 | 29/02/2016 |
Susannah Gray
BRD | Director/Board Member | 65 | 31/10/2020 |
Gregory Lucier
BRD | Director/Board Member | 61 | 31/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/10/26 | Tax | Chief Executive Officer | -29,250 | 0.0196% | ||
| 30/09/26 | Tax | Chief Financial Officer | -5,465 | 0.0037% | ||
| 08/09/26 | Tax | Chief Executive Officer | -29,250 | 0.0196% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.68% | +10.47% | +154.40% | +25.56% | 1.26B | |
| -0.62% | +0.50% | +33.92% | +60.07% | 64.38B | |
| +0.35% | +3.04% | +12.64% | +83.62% | 56.16B | |
| +0.53% | +2.55% | +13.90% | +104.77% | 54.16B | |
| -2.81% | -3.95% | +22.72% | +48.57% | 45.33B | |
| -0.33% | -3.12% | +17.62% | +117.27% | 42.25B | |
| +0.55% | +1.93% | +229.73% | +928.00% | 40.78B | |
| +3.27% | +47.40% | +110.44% | +94.92% | 33.8B | |
| +1.22% | -1.39% | +13.92% | +46.95% | 32.25B | |
| -1.29% | -1.72% | +21.00% | -6.85% | 23.57B | |
| Average | -0.69% | +6.22% | +63.03% | +150.29% | 39.39B | |
| Weighted average by Cap. | -0.02% | +3.69% | +49.91% | +162.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 212M 190M 174M 158M 295M 20.11B 301M 2.08B 835M 10.58B 795M 778M 33.36B | 225M 201M 185M 168M 314M 21.35B 320M 2.21B 887M 11.23B 844M 826M 35.42B |
| Net income | -55.79M -49.97M -45.96M -41.65M -77.85M -5.3B -79.3M -548M -220M -2.79B -209M -205M -8.79B | -40.65M -36.4M -33.49M -30.34M -56.71M -3.86B -57.78M -399M -160M -2.03B -153M -149M -6.4B |
| Net Debt | 93.41M 83.66M 76.95M 69.73M 130M 8.87B 133M 918M 368M 4.67B 351M 343M 14.71B | 58.85M 52.71M 48.49M 43.93M 82.12M 5.59B 83.66M 578M 232M 2.94B 221M 216M 9.27B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$7.810 | -7.68% | 1,703,904 |
| 29/10/26 | US$8.460 | -0.47% | 1,385,342 |
| 28/10/26 | US$8.500 | +2.91% | 2,779,396 |
| 27/10/26 | US$8.260 | +8.97% | 3,110,351 |
| 26/10/26 | US$7.580 | +3.55% | 1,285,235 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRVI Stock
Select your edition
All financial news and data tailored to specific country editions
